Freenome is an AI genomics company on a mission to empower everyone with the tools they need to detect, treat, and ultimately prevent their diseases. By applying advanced machine learning techniques to recent breakthroughs in genomic science, Freenome is developing noninvasive blood tests to detect early-stage cancer and improve precision oncology treatments for patients everywhere. The company has raised $240 million from investors such as Andreessen Horowitz, Google Ventures, Polaris Partners, and Founders Fund. More information at: https://www.freenome.com/
For those who crave challenges, understudied problems, and the chance to see their work impact millions of lives touched by cancer, there’s no better place to be. Ready to join the fight? Search available positions and get in touch at: https://www.freenome.com/careers
